INVO Fertility, Inc. Common Stock (IVF) Q3 2024 Earnings
IVF·Reported November 19, 2024·Before market open
INVO Fertility, Inc. Common Stock reported Q3 2024 revenue of $1.4M, missed analyst consensus of $4.0M by $2.6M. Diluted EPS came in at $-5.04, beat the $-25.92 consensus by $20.88.
Revenue
$1.4Mmissed by $2.6M
Consensus: $4.0MDiluted EPS
$-5.04beat by $20.88
Consensus: $-25.92
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about INVO Fertility, Inc. Common Stock's Q3 2024 earnings report.
INVO Fertility, Inc. Common Stock (IVF) reported Q3 2024 earnings on November 19, 2024 before market open.
INVO Fertility, Inc. Common Stock reported revenue of $1.4M and diluted EPS of $-5.04 for Q3 2024.
Revenue missed the consensus estimate of $4.0M by $2.6M. EPS beat the consensus estimate of $-25.92 by $20.88.
You can read the 10-Q periodic report (0001493152-24-046822) directly on SEC EDGAR. The filing index links above go to sec.gov.